|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 207/48 | |
| A61K 31/40 |
| (11) | Number of the document | 3433233 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17770546.4 |
| Date of filing the European patent application | 2017-03-17 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2017/002914 |
| Date | 2017-03-17 |
| (87) | Number | WO 2017/164576 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 20160036080 | 2016-03-25 | KR |
| (72) |
KIM, Aeri, KR
CHO, Kwan Hyung, KR
|
| (73) |
Daewoong Pharmaceutical Co., Ltd.,
35-14, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si Gyenoggi-do 18623,
KR
|
| (54) | NOVEL CRYSTALLINE FORM OF 1-(5-(2,4-DIFLUOROPHENYL)-1-((3- FLUOROPHENYL)SULFONYL)-4-METHOXY-1H-PYRROL-3-YL)-N- METHYLMETHANAMINE SALT |
| NOVEL CRYSTALLINE FORM OF 1-(5-(2,4-DIFLUOROPHENYL)-1-((3- FLUOROPHENYL)SULFONYL)-4-METHOXY-1H-PYRROL-3-YL)-N- METHYLMETHANAMINE SALT |